Recent Myocardial Infarction: Clinical Trials

2 trials for Recent Myocardial Infarction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Recruiting 1

Follow Recent Myocardial Infarction: new trials by email Literature Review of Recent Myocardial Infarction trials Research Report on Recent Myocardial Infarction

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Pharmacokinetics and Pharmacodynamics Study of Evategrel CG-0255 Besylate)and Plavix® in Healthy Participants
CG-0255 Besylate for Injection, CG-0255 Besylate Capsule, Clopidogrel - Acute Coronary Syndromes (ACS), Recent Myocardial Infarction
Phase 1RecruitingShanghai CureGene Pharmaceutical Co., Ltd.1362026-06-012026-06-29
CArdiosphere-Derived aUtologous Stem CElls to Reverse ventricUlar dySfunction
Autologous stem cell infusion - Recent Myocardial Infarction, Ventricular Dysfunction
Phase 1CompletedCedars-Sinai Medical Center312009-05-012014-02-12

Narrower conditions

Acute Coronary Syndrome (1)  ·  Myocardial Infarction (1)  ·  Peripheral Arterial Disease (1)  ·  Ventricular Dysfunction (1)

Broader conditions

Cardiovascular Diseases (2)  ·  Heart Diseases (2)  ·  Myocardial Ischemia (2)  ·  Vascular Diseases (2)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Atherosclerosis (1)  ·  Infarction (1)  ·  Ischemia (1)  ·  Necrosis (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Peripheral Vascular Diseases (1)

Interventions

Clopidogrel (1)  ·  Injections (1)

Sponsors

Cedars-Sinai Medical Center (1)  ·  Shanghai CureGene Pharmaceutical Co., Ltd. (1)

Countries

United States (2)

Top investigators

Eduardo Marban, MD, PhD (1)

Results publications

PMID 21330601, PMID 21454794, PMID 22336189, PMID 24036024

NIH funding

U54HL081028 (1)